Saba Luca, Maindarkar Mahesh, Khanna Narendra N., Johri Amer M., Mantella Laura, Laird John R., . . . et al. (2023). A Pharmaceutical Paradigm for Cardiovascular Composite Risk Assessment Using Novel Radiogenomics Risk Predictors in Precision Explainable Artificial Intelligence Framework: Clinical Trial Tool.
Chicago Style (17th ed.) CitationSaba Luca, et al. A Pharmaceutical Paradigm for Cardiovascular Composite Risk Assessment Using Novel Radiogenomics Risk Predictors in Precision Explainable Artificial Intelligence Framework: Clinical Trial Tool. 2023.
MLA idézésSaba Luca, et al. A Pharmaceutical Paradigm for Cardiovascular Composite Risk Assessment Using Novel Radiogenomics Risk Predictors in Precision Explainable Artificial Intelligence Framework: Clinical Trial Tool. 2023.